Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kieran Cashin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Plos One|October 15, 2014
Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithmsKieran Cashin, Jasminka Sterjovski, Katherine L Harvey, et al.
Retrovirology|March 1, 2013
CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithmKieran Cashin, Lachlan R Gray, Martin R Jakobsen, et al.
Retrovirology|November 13, 2014
Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cellsKieran Cashin, Geza Paukovics, Martin R Jakobsen, et al.
Viruses|February 13, 2014
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strainsJacqueline K Flynn, Geza Paukovics, Kieran Cashin, et al.
Journal of Virology|August 13, 2011
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophagesKieran Cashin, Michael Roche, Jasminka Sterjovski, et al.
Retrovirology|September 18, 2013
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infectionKieran Cashin, Martin R Jakobsen, Jasminka Sterjovski, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Scientific Reports|February 26, 2015
Reliable genotypic tropism tests for the major HIV-1 subtypesKieran Cashin, Lachlan R Gray, Katherine L Harvey, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Plos One|October 15, 2014
Covariance of charged amino acids at positions 322 and 440 of HIV-1 Env contributes to coreceptor specificity of subtype B viruses, and can be used to improve the performance of V3 sequence-based coreceptor usage prediction algorithmsKieran Cashin, Jasminka Sterjovski, Katherine L Harvey, et al.
Retrovirology|March 1, 2013
CoRSeqV3-C: a novel HIV-1 subtype C specific V3 sequence based coreceptor usage prediction algorithmKieran Cashin, Lachlan R Gray, Martin R Jakobsen, et al.
Retrovirology|November 13, 2014
Differences in coreceptor specificity contribute to alternative tropism of HIV-1 subtype C for CD4(+) T-cell subsets, including stem cell memory T-cellsKieran Cashin, Geza Paukovics, Martin R Jakobsen, et al.
Viruses|February 13, 2014
Quantifying susceptibility of CD4+ stem memory T-cells to infection by laboratory adapted and clinical HIV-1 strainsJacqueline K Flynn, Geza Paukovics, Kieran Cashin, et al.
Journal of Virology|August 13, 2011
Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophagesKieran Cashin, Michael Roche, Jasminka Sterjovski, et al.
Retrovirology|September 18, 2013
Linkages between HIV-1 specificity for CCR5 or CXCR4 and in vitro usage of alternative coreceptors during progressive HIV-1 subtype C infectionKieran Cashin, Martin R Jakobsen, Jasminka Sterjovski, et al.
Retrovirology|November 5, 2016
Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maravirocKatharina Borm, Martin R Jakobsen, Kieran Cashin, et al.
Journal of Virology|December 20, 2019
CXCR4-Using HIV Strains Predominate in Naive and Central Memory CD4<sup>+</sup> T Cells in People Living with HIV on Antiretroviral Therapy: Implications for How Latency Is Established and MaintainedMichael Roche, Carolin Tumpach, Jori Symons, et al.
Scientific Reports|February 26, 2015
Reliable genotypic tropism tests for the major HIV-1 subtypesKieran Cashin, Lachlan R Gray, Katherine L Harvey, et al.
AIDS Research and Human Retroviruses|August 12, 2017
Analysis of Clinical HIV-1 Strains with Resistance to Maraviroc Reveals Strain-Specific Resistance Mutations, Variable Degrees of Resistance, and Minimal Cross-Resistance to Other CCR5 AntagonistsJacqueline K Flynn, Paula Ellenberg, Renee Duncan, et al.
Pageof 2